Seoul National University Hospital
Seoul, Jongno, 03080, South Korea
Location status: Recruiting
Location contact
junghyun kim, Ph. D.
CONTACT
82+1021740890
NCT Number: NCT06380049
The study assesses a machine learning model developed to predict fall risk among stroke patients using multi-sensor signals. This prospective, multicenter, open-label, sponsor-initiated confirmatory trial aims to validate the safety and efficacy of the model which utilizes electromyography (EMG) signals to categorize patients into high-risk or low-risk fall categories. The innovative approach hopes to offer a predictive tool that enhances preventative strategies in clinical settings, potentially reducing fall-related injuries in stroke survivors.
Interested in participating?
Request Info19 year and older
All sexes
Observational
Seoul, Jongno, 03080, South Korea
Location status: Recruiting
junghyun kim, Ph. D.
CONTACT
82+1021740890
Objective: The primary objective is to develop and validate a machine learning-based model that uses multi-sensor (EMG) signals to identify stroke patients at high risk of falls. This model aims to improve on traditional fall risk assessments which rely heavily on physical assessments and patient history.
Study Design: This is a prospective, multicenter, open-label, confirmatory clinical trial. It involves collecting EMG data from stroke patients and applying machine learning techniques to predict fall risk. The study will compare the predictive accuracy of the machine learning model against conventional fall risk assessment tools.
Methods:
Data Collection:
Statistical Analysis:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Stroke Participants
Inclusion criteria
Exclusion criteria
Health Participants
Inclusion criteria
Exclusion criteria
Surface electromyography devices are non-invasive tools that measure electrical activity produced by skeletal muscles through sensors placed on the skin.
Time frame: At the time of the single visit
The primary outcome measure is the sensitivity of the machine learning model, which refers to its ability to correctly identify patients who are at high risk of falls. Sensitivity is defined as the proportion of actual positives that are correctly identified.
Time frame: At the time of the single visit
Specificity measures the proportion of actual negatives that are correctly identified.
Time frame: At the time of the single visit
This is a performance measurement for classification problems at various threshold settings. ROC is a probability curve, and AUC represents the degree or measure of separability. It tells how much the model is capable of distinguishing between classes.
Time frame: At the time of the single visit
The MCC is used in machine learning as a measure of the quality of binary classifications. It takes into account true and false positives and negatives and is generally regarded as a balanced measure which can be used even if the classes are of very different sizes.
Contact information is provided by the study sponsor or research team.
Seoul National University Hospital
Other
Development and Validation of a Machine Learning-based Model to Predict a High-risk Group for Falls Using Multi-sensor Signals in Stroke Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06061887
Brain Diseases, Cardiovascular Diseases
Izmir, Turkey (Türkiye)
View Trial DetailsNCT04844476
Brain Diseases, Cardiovascular Diseases
Izmir, Turkey (Türkiye)
View Trial DetailsNCT03409354
Brain Diseases, Bursitis
Singapore
View Trial DetailsNCT03592420
Aging, Basal Ganglia Diseases
Modena, Italy
View Trial Details